Copyright
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Feb 6, 2023; 11(4): 764-779
Published online Feb 6, 2023. doi: 10.12998/wjcc.v11.i4.764
Published online Feb 6, 2023. doi: 10.12998/wjcc.v11.i4.764
Major depressive disorders in patients with inflammatory bowel disease and rheumatoid arthritis
Maryam Bilal Haider, Department of Internal Medicine, Detroit Medical Center, Wayne State University, Sinai Grace Hospital, Detroit, MI 48235, United States
Brinda Basida, Department of Geriatrics, Rohde Island Hospital/Brown University, Providence, RI 02903, United States
Jasleen Kaur, Department of Rheumatology, St. Mary’s Ascension/Central Michigan University, Saginaw, MI 48601, United States
Author contributions: Haider MB, Basida B and Kaur J contributed equally to this work; Haider MB and Kaur J designed the research study; Kaur J and Basida B performed the research; Haider MB analyzed the data; Haider MB, Basida B and Kaur J wrote the manuscript; All authors have read and approve the final manuscript.
Institutional review board statement: Data from this study used de-identified data from the National Inpatient Sample Database (NIS) 2000-2019. A publicly available all-payer inpatient care database in the United States. Institutional Review Board Approval Form or Document is not required.
Informed consent statement: Data from this study used de-identified data from the National Inpatient Sample Database. A publicly available all-payer inpatient care database in the United States. Informed patient consent is not required.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: Data that support the findings of this study are publicly available at https://www.hcup-us.ahrq.gov/db/nation/nis/nisdbdocumentation.jsp.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Maryam Bilal Haider, MD, Doctor, Department of Internal Medicine, Detroit Medical Center, Wayne State University, Sinai Grace Hospital, 6071 Outer Dr W, Detroit, MI 48235, United States. maryambilalhaider@yahoo.com
Received: September 21, 2022
Peer-review started: September 21, 2022
First decision: November 30, 2022
Revised: December 14, 2022
Accepted: January 12, 2023
Article in press: January 12, 2023
Published online: February 6, 2023
Processing time: 137 Days and 18.9 Hours
Peer-review started: September 21, 2022
First decision: November 30, 2022
Revised: December 14, 2022
Accepted: January 12, 2023
Article in press: January 12, 2023
Published online: February 6, 2023
Processing time: 137 Days and 18.9 Hours
Core Tip
Core Tip: Our study is a nationwide inpatient sample-based study of the two decades in which we aim to analyze inflammatory bowel disease (IBD) and rheumatoid arthritis (RA) patients’ characteristics, temporal trends, sociodemographic characteristics, and predictors of major depressive disorders in the IBD-RA cohort. There is an increasing trend in the prevalence of IBD-RA, especially in younger patients. We believe this study will open the door for further research and educate the involved physicians to identify the early signs and symptoms of depression in patients with IBD or RA or IBD-RA combined and treat them or have them treated to have a better overall prognosis.